Invitae completes sale of reproductive health assets to Natera

Invitae (NVTA) announced it has completed the sale of certain reproductive health assets, which include carrier screening and non-invasive prenatal screening, to Natera (NTRA). The value of the transaction is up to $52.5M, including cash, milestone payments and litigation credits. Natera has hired Invitae reproductive health sales representatives. In addition, Invitae will transition its non-invasive prenatal screening and carrier screening customers to Natera. This transaction will aid Invitae’s efforts to significantly reduce operating expenses. The company anticipates annualized operating expense cash savings of approximately $44M from the sale, excluding one-time severance related payments.